Skip to content
★ Sign in to follow
OA

Ortivus AB ser. A Stock: price and insider trades · Sweden

ISIN SE0000188930SE·Health Care

No insider purchase over the last 90 days. The latest, by KONSTANTIN PAPAXANTHIS, was filed 28 Sept 2017.

Ortivus AB ser. A: what insiders have been doing

Only a handful of insider records exist for Ortivus AB ser. A, the last one from 28 September 2017, too few to describe a trend. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.

Insider Decl.
1
Thresholds
n/a
Buy Volume
€2,509
1 ops. · all time
Sell Volume
n/a
n/a

Since the insiders bought

  • Filed 28 Sept 2017 · 3327 days ago · €2,509
    -68.9%
    Entry SEK 11.15 · Close at T+365 SEK 3.47

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Financial data

as of FY 2025

FY ended December 2025 · cache

SEK 1.72
Analyst consensus
·
Income statement
RevenueSEK 73.4M
Gross profitSEK 29.6M40% margin
EBITDA-SEK 14.7M-20% margin
Net income-SEK 21.9M-23.4% margin
Valuation
P/Book8.6x
Beta0.94
Balance sheet & cash
Total debtSEK 19.5M
Free Cash Flow-SEK 34.8M
Debt / Equity172%
Profitability & ownership
ROE-2201.4%
ROA-17.3%
% insiders48.0%
% institutions2.4%
Last declaration on 28 September 2017
Declarations1 total
  • ▲
    Styrelseledamot/suppleantExecutives
    24,000 SEK15FI-SE
    2,000 shares@ SEK 12.00100.0% of flowISIN SE0000188930FI:csv-800ea1a2c4e0df7a5e8e
    Canonical exit: 27 Dec 2017 (T+90)

1 of 1 declaration

About Ortivus AB ser. A

Ortivus AB ser. A is a Swedish company specializing in digital health solutions. It develops systems for patient monitoring and management.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations